A poly(ethylene) glycolylated peptide for ocular delivery compacts DNA into nanoparticles for gene delivery to post-mitotic tissues in vivo.

The Journal of Gene Medicine
Sarah Parker ReadRajendra Kumar-Singh

Abstract

We have previously shown that a novel synthetic peptide for ocular delivery (POD) can efficiently compact DNA and deliver it to cells in vitro. This observation prompted us to develop use of POD as a nonviral vector in vivo. POD peptide was modified using poly(ethylene) glycol (PEG-POD) and used to compact DNA into nanoparticles that were then analysed using electron microscopy, dynamic light scattering, and fluorescent labeling. Transfection efficiency and localization were determined 48 h post-injection into the subretinal space of the mouse eye using luciferase and LacZ, respectively. Efficiency of ocular transfection was compared to two other PEGylated peptides: PEG-TAT and PEG-CK30. PEG-POD can compact DNA and form discrete nanoparticles of approximately 136 nm that can penetrate and transduce the retinal pigment epithelium (RPE) in vivo. PEG-POD significantly increased expression of plasmid DNA by 215-fold, PEG-TAT by 56.52-fold, and PEG-CK30 by 24.73-fold relative to DNA injected alone. In all cases beta-galactosidase was observed primarily in the RPE layer after subretinal injection. Electrophysiological analyses of PEG-POD transduced retina indicates an absence of PEG-POD-mediated toxicity. PEG-POD can protect plasmid ...Continue Reading

References

Apr 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·W C Shen, H J Ryser
Jan 10, 2003·The Journal of Biological Chemistry·Carsten RudolphJoseph Rosenecker
Jun 17, 2003·The Journal of Biological Chemistry·Ge LiuMark J Cooper
Dec 11, 2003·Molecular Therapy : the Journal of the American Society of Gene Therapy·Assem-Galal ZiadyPamela B Davis
Dec 11, 2003·Molecular Therapy : the Journal of the American Society of Gene Therapy·Assem-Galal ZiadyPamela B Davis
Jan 31, 2004·Clinical Chemistry·Haruo TakeshitaKoichiro Kishi
Mar 25, 2005·Gene Therapy·S KachiP A Campochiaro
May 24, 2005·Gene Therapy·D A DeanW E Zimmer
Jul 30, 2005·Proceedings of the National Academy of Sciences of the United States of America·Dhruba J BharaliMichal K Stachowiak
Dec 21, 2006·Journal of Pharmaceutical Sciences·M S WardM J Young
Apr 6, 2007·The AAPS Journal·Pamela B Davis, Mark J Cooper
Oct 10, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Leslie N JohnsonRajendra Kumar-Singh
Jun 21, 2008·Vision Research·Rajendra Kumar-Singh

❮ Previous
Next ❯

Citations

Aug 12, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Sarah P ReadRajendra Kumar-Singh
Oct 12, 2010·Journal of Angiogenesis Research·Krysten M Farjo, Jian-Xing Ma
Oct 5, 2011·Indian Journal of Pharmaceutical Sciences·R K KharF J Ahmad
Aug 16, 2014·Progress in Retinal and Eye Research·Ivana TrapaniAlberto Auricchio
May 19, 2012·Expert Opinion on Drug Delivery·Taavi LehtoÜlo Langel
Jun 26, 2015·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Rajendra Narayan MitraZongchao Han
Apr 17, 2012·Drug Discovery Today·Gaurav K JainRoop K Khar
Sep 3, 2011·Biomaterials·Adarsha KoiralaMuna I Naash
May 11, 2010·Progress in Retinal and Eye Research·Shannon M Conley, Muna I Naash
Feb 24, 2011·The Journal of Gene Medicine·Christina BinderRajendra Kumar-Singh
May 8, 2013·Expert Opinion on Drug Metabolism & Toxicology·Joaquín Jordán, José M Ruíz-Moreno
Jun 19, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Afrouz YousefiEnrico Mastrobattista
Jul 12, 2016·ACS Applied Materials & Interfaces·Chang LiuWeisan Pan
Jun 20, 2019·Journal of Biomaterials Science. Polymer Edition·Joyce PintoBharath Raja Guru
Jul 3, 2021·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Sujithra ShankarArchana Chugh
Jun 12, 2017·ACS Biomaterials Science & Engineering·Yangzi TianYubing Xie

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Molecular Therapy : the Journal of the American Society of Gene Therapy
Leslie N JohnsonRajendra Kumar-Singh
Molecular Therapy : the Journal of the American Society of Gene Therapy
Sarah Parker ReadRajendra Kumar-Singh
Molecular Therapy : the Journal of the American Society of Gene Therapy
Xuguang ChenPamela B Davis
Gene Therapy
Shu KachiPeter A Campochiaro
© 2022 Meta ULC. All rights reserved